100 related articles for article (PubMed ID: 1665995)
21. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
Lee JH; el-Fakahany EE
J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
[TBL] [Abstract][Full Text] [Related]
23. Quinuclidinyl benzilate binding in house fly heads and rat brain.
Jones SW; Sumikawa K
J Neurochem; 1981 Feb; 36(2):454-9. PubMed ID: 7463072
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
Vickroy TW; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
[TBL] [Abstract][Full Text] [Related]
25. Solubilization and partial purification from mouse sperm membranes of the specific binding activity for 3-quinuclidinyl benzilate, a potent inhibitor of the zona pellucida-induced acrosome reaction.
Ward CR; Kopf GS; Storey BT
Mol Reprod Dev; 1994 Dec; 39(4):423-32. PubMed ID: 7893491
[TBL] [Abstract][Full Text] [Related]
26. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
27. Studies of muscarinic and nicotinic binding sites in brain.
Nordberg A; Larsson C
Acta Physiol Scand Suppl; 1980; 479():19-23. PubMed ID: 6932800
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
Dunlap J; Brown JH
Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
[TBL] [Abstract][Full Text] [Related]
29. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
30. Muscarinic cholinergic receptors in mouse pituitary tumor cells: prolonged agonist pretreatment decreases receptor content and increases forskolin- and hormone-stimulated cyclic AMP synthesis and adrenocorticotropin secretion.
Heisler S; Desjardins D; Nguyen MH
J Pharmacol Exp Ther; 1985 Jan; 232(1):232-8. PubMed ID: 2981317
[TBL] [Abstract][Full Text] [Related]
31. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
Wang JX; Mei L; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203
[TBL] [Abstract][Full Text] [Related]
32. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
[TBL] [Abstract][Full Text] [Related]
33. Muscarinic and nicotinic cholinergic binding sites in the terminal abdominal ganglion of the cricket (Acheta domesticus).
Meyer MR; Reddy GR
J Neurochem; 1985 Oct; 45(4):1101-12. PubMed ID: 2993520
[TBL] [Abstract][Full Text] [Related]
34. Differential distribution of muscarinic cholinergic and putative nicotinic cholinergic receptors within the hypothalamo-neurohypophysial system of the rat.
Michels KM; Meeker RB; Hayward JN
Neuroendocrinology; 1986; 44(4):498-507. PubMed ID: 3822079
[TBL] [Abstract][Full Text] [Related]
35. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.
Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M
Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596
[TBL] [Abstract][Full Text] [Related]
36. An autoradiographic analysis of cholinergic receptors in mouse brain.
Pauly JR; Stitzel JA; Marks MJ; Collins AC
Brain Res Bull; 1989 Feb; 22(2):453-9. PubMed ID: 2706548
[TBL] [Abstract][Full Text] [Related]
37. Regional and subcellular distribution of cholinergic enzyme and receptor activity in goldfish brain.
Francis A; Schechter N
Neuroscience; 1980; 5(2):293-301. PubMed ID: 7374943
[No Abstract] [Full Text] [Related]
38. Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury.
Verbois SL; Scheff SW; Pauly JR
J Neurotrauma; 2002 Dec; 19(12):1569-85. PubMed ID: 12542858
[TBL] [Abstract][Full Text] [Related]
39. Muscarinic cholinergic receptors in human infant forebrain: [3H]quinuclidinyl benzilate binding in homogenates and quantitative autoradiography in sections.
Johnston MV; Silverstein FS; Reindel FO; Penney JB; Young AB
Brain Res; 1985 Apr; 351(2):195-203. PubMed ID: 3995346
[TBL] [Abstract][Full Text] [Related]
40. Changes in binding to muscarinic and nicotinic cholinergic receptors in the chick telencephalon, following passive avoidance learning.
Mezey S; Székely AD; Bourne RC; Kabai P; Csillag A
Neurosci Lett; 1999 Jul; 270(2):75-8. PubMed ID: 10462101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
